Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

781
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
781
Metastasis02:30

Metastasis

5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinoma.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Co-Existent Endometrial and Fallopian Tube Carcinoma, Molecular and Pathological Features for Risk Stratification.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

The levonorgestrel intrauterine device and ovarian cancer risk: a population-based study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Vulvar Squamous Cell Carcinoma: Scientific Progress and Impacts to Pathology Practice.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·2026
Same author

Assessing the essential parameters of race, ethnicity and geography in endometrial cancer and the impact on presentation, treatment and outcomes.

Gynecologic oncology·2026
Same author

Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators.

Journal of the National Cancer Institute·2026
Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026
Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: Sep 27, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.2K

Endometrial cancer.

Emma J Crosbie1, Sarah J Kitson2, Jessica N McAlpine3

  • 1Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK; Department of Obstetrics and Gynaecology, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Lancet (London, England)
|April 10, 2022
PubMed
Summary
This summary is machine-generated.

Endometrial cancer, a rising global concern primarily driven by obesity, requires advancements in prevention and treatment. Research is crucial for improving outcomes in high-risk women and optimizing survivorship for all patients.

More Related Videos

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.0K
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.8K

Related Experiment Videos

Last Updated: Sep 27, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.2K
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.0K
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.8K

Area of Science:

  • Gynecologic Oncology
  • Cancer Epidemiology
  • Obesity and Cancer Research

Background:

  • Endometrial cancer is the most common gynecologic malignancy in high-income nations, with a rising global incidence.
  • Increasing obesity prevalence is identified as the primary driver of this trend, posing significant diagnostic and therapeutic challenges.
  • While early-stage disease is often curable with hysterectomy, advanced endometrial cancer presents a poor prognosis, necessitating improved strategies.

Purpose of the Study:

  • To review current trends, challenges, and advancements in the diagnosis, treatment, and prevention of endometrial cancer.
  • To highlight the impact of obesity on endometrial cancer incidence and management.
  • To discuss emerging molecular insights and future therapeutic directions for endometrial cancer.

Main Methods:

  • Literature review of epidemiological data, diagnostic modalities, surgical techniques, and adjuvant therapies for endometrial cancer.
  • Analysis of the role of obesity in endometrial cancer development and progression.
  • Exploration of recent advances in molecular biology and their translation into targeted therapies.

Main Results:

  • Minimally invasive surgical staging and sentinel lymph node biopsy offer reduced morbidity compared to traditional methods without compromising oncological outcomes.
  • Adjuvant radiotherapy effectively decreases loco-regional recurrence in intermediate- and high-risk endometrial cancer cases.
  • Understanding of endometrial cancer's molecular biology is enabling the development of targeted chemotherapeutic strategies for various disease settings.

Conclusions:

  • Obesity is a critical factor in the rising incidence of endometrial cancer, demanding focused primary prevention efforts.
  • Current surgical and adjuvant treatments, including minimally invasive techniques and radiotherapy, improve outcomes for specific patient groups.
  • Targeted therapies based on molecular profiling hold significant promise for improving adjuvant, advanced, and recurrent endometrial cancer treatment in the future.